PD-(L)1 Resistance HopePD-1Explore how LRRC15+ CAFs contribute to PD-1 resistance, the role of LRRC15 in tumor immunity, and emerging therapies targeting LRRC15 and PD-1 to improve cancer immunotherapy outcomes.
Brain Cancer and Scientific LoveImmunotherapyProfessor Richard Scolyer, a world-leading melanoma expert, bravely pioneered experimental immunotherapy for brain cancer, offering new hope for glioblastoma treatment worldwide.
